Melanoma Trial, Recruiting NCT06272864 Sponsor: BostonGene Condition: Melanoma
Back to Melanoma

Melanoma Trial, Recruiting

NCT06272864
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with one of the following cancers: breast cancer that has come back, cannot be surgically removed, or has spread to other parts of the body; non-small cell lung cancer that is at an advanced stage (Stage III) and cannot be surgically removed, or has spread; melanoma (a type of skin cancer) that cannot be surgically removed or has spread; or sarcoma (a cancer of the bones or soft tissues) that is at an advanced stage or has spread
  • People whose treating doctor estimates they have a life expectancy of more than 3 months
  • People who are willing to give formal consent to take part in the trial
  • People who are living in the United States at the time they enroll
  • People who agree to have their genes and cancer cells analyzed as part of the study (genomic and molecular profiling)

Who may not be able to join:

  • People who do not meet all of the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 650-773-0771

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
BostonGene
Registry
ClinicalTrials.gov
Start date
8 April 2024
Est. completion
8 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Frequency of actionable findings; Test turn-around time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov